Global Multiparticulate Drug Delivery System Market Research Report 2025

Publication ID:

PB505253662

Publication Date:

May 19, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Multiparticulate Drug Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Multiparticulate systems also face some challenges, such as production equipment limitations, long production steps, many influencing factors, and potential healing and stability issues. Take pellet tableting as an example. Due to the difficulty of the pellet tableting process, although the product can improve bioavailability, reduce drug dosage, and alleviate adverse reactions, it is easy to delaminate during the tableting process, and the coating film becomes compressed after being coated. It is easy to break, and the pellets collide and fuse with each other when pressed into tablets, and cannot quickly disintegrate into a single pellet in the gastrointestinal tract after taking it.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multiparticulate Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiparticulate Drug Delivery System.
The Multiparticulate Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multiparticulate Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiparticulate Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Elan drug Technologies
Rochling Group
Janssen
Pfizer
Novartis
GlaxoSmithKline
Sanofi
Bayer
Segment by Type
Granules
Micropills
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Multiparticulate Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Multiparticulate Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Multiparticulate Drug Delivery System Market Overview
1.1 Product Definition
1.2 Multiparticulate Drug Delivery System by Type
1.2.1 Global Multiparticulate Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Granules
1.2.3 Micropills
1.3 Multiparticulate Drug Delivery System by Application
1.3.1 Global Multiparticulate Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Multiparticulate Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Multiparticulate Drug Delivery System Revenue 2020-2031
1.4.2 Global Multiparticulate Drug Delivery System Sales 2020-2031
1.4.3 Global Multiparticulate Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Multiparticulate Drug Delivery System Market Competition by Manufacturers
2.1 Global Multiparticulate Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Multiparticulate Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Multiparticulate Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Multiparticulate Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Multiparticulate Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Multiparticulate Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Multiparticulate Drug Delivery System, Date of Enter into This Industry
2.8 Global Multiparticulate Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Multiparticulate Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Multiparticulate Drug Delivery System Players Market Share by Revenue
2.8.3 Global Multiparticulate Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Multiparticulate Drug Delivery System Market Scenario by Region
3.1 Global Multiparticulate Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Multiparticulate Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Multiparticulate Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Multiparticulate Drug Delivery System Sales by Region: 2026-2031
3.3 Global Multiparticulate Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Multiparticulate Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Multiparticulate Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Multiparticulate Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Multiparticulate Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Multiparticulate Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Multiparticulate Drug Delivery System Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multiparticulate Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Multiparticulate Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Multiparticulate Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Multiparticulate Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multiparticulate Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Multiparticulate Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Multiparticulate Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Multiparticulate Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Multiparticulate Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Multiparticulate Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Multiparticulate Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Multiparticulate Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Multiparticulate Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Multiparticulate Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Multiparticulate Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Multiparticulate Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multiparticulate Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Multiparticulate Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Multiparticulate Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Multiparticulate Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Multiparticulate Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Multiparticulate Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Multiparticulate Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Multiparticulate Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Multiparticulate Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Multiparticulate Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Multiparticulate Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Multiparticulate Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Multiparticulate Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Multiparticulate Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Multiparticulate Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Multiparticulate Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Multiparticulate Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Multiparticulate Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Elan drug Technologies
6.1.1 Elan drug Technologies Company Information
6.1.2 Elan drug Technologies Description and Business Overview
6.1.3 Elan drug Technologies Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Elan drug Technologies Multiparticulate Drug Delivery System Product Portfolio
6.1.5 Elan drug Technologies Recent Developments/Updates
6.2 Rochling Group
6.2.1 Rochling Group Company Information
6.2.2 Rochling Group Description and Business Overview
6.2.3 Rochling Group Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Rochling Group Multiparticulate Drug Delivery System Product Portfolio
6.2.5 Rochling Group Recent Developments/Updates
6.3 Janssen
6.3.1 Janssen Company Information
6.3.2 Janssen Description and Business Overview
6.3.3 Janssen Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Janssen Multiparticulate Drug Delivery System Product Portfolio
6.3.5 Janssen Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Multiparticulate Drug Delivery System Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Multiparticulate Drug Delivery System Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Company Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GlaxoSmithKline Multiparticulate Drug Delivery System Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Sanofi
6.7.1 Sanofi Company Information
6.7.2 Sanofi Description and Business Overview
6.7.3 Sanofi Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Multiparticulate Drug Delivery System Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Multiparticulate Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer Multiparticulate Drug Delivery System Product Portfolio
6.8.5 Bayer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multiparticulate Drug Delivery System Industry Chain Analysis
7.2 Multiparticulate Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multiparticulate Drug Delivery System Production Mode & Process Analysis
7.4 Multiparticulate Drug Delivery System Sales and Marketing
7.4.1 Multiparticulate Drug Delivery System Sales Channels
7.4.2 Multiparticulate Drug Delivery System Distributors
7.5 Multiparticulate Drug Delivery System Customer Analysis
8 Multiparticulate Drug Delivery System Market Dynamics
8.1 Multiparticulate Drug Delivery System Industry Trends
8.2 Multiparticulate Drug Delivery System Market Drivers
8.3 Multiparticulate Drug Delivery System Market Challenges
8.4 Multiparticulate Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Elan drug Technologies
Rochling Group
Janssen
Pfizer
Novartis
GlaxoSmithKline
Sanofi
Bayer

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂